Evaxion Biotech A/S (EVAX)

Evaxion Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.58	5.58	13.18	32.17	5.83	9.56
Cash & Short-Term Investments	4.58	5.58	13.18	32.17	5.83	9.56
Cash Growth	75.66%	-57.65%	-59.01%	451.35%	-38.97%	28.60%
Other Receivables	-	1.08	1.31	1.9	2.21	0.93
Receivables	-	1.08	1.31	1.9	2.21	0.93
Prepaid Expenses	-	1.69	2.49	0.64	1.18	0.47
Other Current Assets	-	-	-	-	1.73	-
Total Current Assets	4.58	8.35	16.99	34.71	10.95	10.96
Property, Plant & Equipment	-	4.34	4.68	5.17	0.22	0.1
Other Intangible Assets	-	-	-	0.09	0.1	-
Long-Term Deferred Tax Assets	-	-	-	-	0.26	-
Other Long-Term Assets	10.61	0.2	0.37	0.19	0.43	0.03
Total Assets	15.19	12.89	22.03	40.16	11.97	11.08
Accounts Payable	-	2.69	2.09	2.85	3.67	0.65
Accrued Expenses	-	0.89	0.35	0.99	1.05	0.86
Current Portion of Long-Term Debt	-	0.16	0.14	0.13	-	-
Current Portion of Leases	-	0.33	0.3	0.31	0.02	0.04
Other Current Liabilities	-	3.02	0.89	0.05	0.18	0.18
Total Current Liabilities	-	7.08	3.76	4.32	4.93	1.72
Long-Term Debt	-	8.49	7.86	1.04	-	-
Long-Term Leases	-	1.9	1.95	2.21	-	-
Other Long-Term Liabilities	15.11	0.15	0.14	0.15	-	-
Total Liabilities	15.11	17.62	13.72	7.73	4.93	1.72
Common Stock	8.73	5.9	3.89	3.76	2.65	2.48
Additional Paid-In Capital	-	87.45	80.73	80.43	31.44	22.86
Retained Earnings	-114.9	-107.97	-85.85	-50.43	-27.28	-15.81
Comprehensive Income & Other	106.25	9.89	9.54	-1.32	0.23	-0.17
Shareholders' Equity	0.07	-4.73	8.3	32.44	7.04	9.36
Total Liabilities & Equity	15.19	12.89	22.03	40.16	11.97	11.08
Total Debt	-	10.87	10.26	3.69	0.02	0.04
Net Cash (Debt)	4.58	-5.29	2.93	28.48	5.81	9.52
Net Cash Growth	-	-	-89.71%	389.78%	-38.95%	-
Net Cash Per Share	4.95	-9.67	6.20	73.04	18.83	34.27
Filing Date Shares Outstanding	1.11	1.04	0.48	0.46	0.38	0.32
Total Common Shares Outstanding	1.11	0.76	0.48	0.46	0.32	0.3
Working Capital	4.58	1.27	13.22	30.38	6.02	9.24
Book Value Per Share	0.07	-6.24	17.20	69.90	21.72	30.83
Tangible Book Value	0.07	-4.73	8.3	32.34	6.94	9.36
Tangible Book Value Per Share	0.07	-6.24	17.20	69.70	21.42	30.83
Machinery	-	1.44	1.37	1.23	0.26	0.09
Leasehold Improvements	-	1.75	1.63	1.57	-	-

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q